- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02973932
iCBT for Children and Adolescents With Obsessive-compulsive Disorder
November 25, 2016 updated by: PD Dr. Annette Conzelmann, University Hospital Tuebingen
Internet-based Cognitive Behavioral Psychotherapy for Children and Adolescents With Obsessive-compulsive Disorder
Internet-based psychotherapy for children and adolescents with obsessive-compulsive symptoms and an age of 7 to 17 years.
Sessions are verified with teleconferencing with an psychotherapist, children and their parents.
The psychotherapy is supported by an App and a wristband to obtain psychophysiological data.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children and adolescents (ages 7-17) with a primary DSM-5 obsessive-compulsive disorder and at least 1 primary caretaker
- German-speaking (child & caretakers)
- Family home equipped with broadband connection and appropriate computer, monitor, HD webcam, and speaker and smart phone
Exclusion Criteria:
- IQ below 70
- A psychiatric comorbidity that makes participation clinically inappropriate (for example, primary anorexia nervosa), depression with suicidality that requires acute treatment, and psychosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Internet-based psychotherapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Schedule for Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime Version (K-SADS-PL)
Time Frame: beginning of the study and end therapy (about 16 weeks)
|
beginning of the study and end therapy (about 16 weeks)
|
|
|
The Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS)
Time Frame: beginning of the study and end therapy (about 16 weeks)
|
beginning of the study and end therapy (about 16 weeks)
|
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: beginning of the study and end therapy (about 16 weeks)
|
beginning of the study and end therapy (about 16 weeks)
|
|
|
Child Behavior Checklist (CBCL)
Time Frame: beginning of the study and end therapy (about 16 weeks)
|
beginning of the study and end therapy (about 16 weeks)
|
|
|
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents (KINDL)
Time Frame: beginning of the study and end therapy (about 16 weeks)
|
beginning of the study and end therapy (about 16 weeks)
|
|
|
Impairment by OCD symptoms
Time Frame: Every day throughout the therapy process (14 weeks)
|
assessed by App
|
Every day throughout the therapy process (14 weeks)
|
|
Extend of avoidance behavior
Time Frame: Every day throughout the therapy process (14 weeks)
|
assessed by App
|
Every day throughout the therapy process (14 weeks)
|
|
Daily mood
Time Frame: Every day throughout the therapy process (14 weeks)
|
assessed by App
|
Every day throughout the therapy process (14 weeks)
|
|
How the day was
Time Frame: Every day throughout the therapy process (14 weeks)
|
assessed by App
|
Every day throughout the therapy process (14 weeks)
|
|
How strong OCD is
Time Frame: Every week throughout the therapy process (14 weeks)
|
assessed by App
|
Every week throughout the therapy process (14 weeks)
|
|
How Every week throughout the therapy processgood e progress was with specific treatment goals
Time Frame: Every week throughout the therapy process (14 weeks)
|
assessed by App
|
Every week throughout the therapy process (14 weeks)
|
|
Anxiety ratings during exposures
Time Frame: Every week three days beginning with session 4 up to 14
|
assessed by App
|
Every week three days beginning with session 4 up to 14
|
|
Heart rate variability
Time Frame: Every day throughout the therapy (14 weeks)
|
assessed with wristband
|
Every day throughout the therapy (14 weeks)
|
|
Skin conductance level
Time Frame: Every day throughout the therapy (14 weeks)
|
assessed with wristband
|
Every day throughout the therapy (14 weeks)
|
|
Body temperature
Time Frame: Every day throughout the therapy (14 weeks)
|
assessed with wristband
|
Every day throughout the therapy (14 weeks)
|
|
Body movements
Time Frame: Every day throughout the therapy (14 weeks)
|
assessed with wristband
|
Every day throughout the therapy (14 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2016
Primary Completion (Anticipated)
November 1, 2017
Study Registration Dates
First Submitted
November 7, 2016
First Submitted That Met QC Criteria
November 25, 2016
First Posted (Estimate)
November 28, 2016
Study Record Updates
Last Update Posted (Estimate)
November 28, 2016
Last Update Submitted That Met QC Criteria
November 25, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F.1331477
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.